One Health targets rising demand in specialist foot and ankle care

One Health Group plc

Investors seeking exposure to the UK’s growing elective healthcare sector should take note of One Health Group’s expanding footprint in foot and ankle surgery, a high-demand specialty where clinical precision meets scalable opportunity.

One Health Group, a Sheffield-based provider of NHS-funded elective surgical care, is making significant strides in foot and ankle treatments. With a network of over 35 outpatient clinics and a team of approximately 130 NHS-trained consultants, the company is addressing a critical area of musculoskeletal health that affects millions across the UK.

The foot and ankle comprise a complex system of 28 bones, 33 joints, and over 100 ligaments, making them susceptible to a range of conditions, from sports injuries to degenerative diseases. One Health’s comprehensive service offering includes both non-invasive and surgical interventions, such as Achilles tendon repairs, total ankle replacements, and subtalar fusions. These procedures are supported by advanced diagnostics, including MRI and CT scans, ensuring accurate assessments and tailored treatment plans.

A key differentiator for One Health is its commitment to continuity of care. Patients are managed by the same consultant throughout their treatment journey, enhancing trust and improving outcomes. This approach is exemplified by consultants like Mr. Matthew Morris, a specialist in lower limb surgery with international training and a focus on foot and ankle procedures. His expertise, combined with the company’s patient-centric model, has garnered a 95.3% inpatient satisfaction rate as of March 2025.

Operational efficiency is another hallmark of One Health’s model. The average waiting time from consultation to treatment ranges between 2 to 12 weeks, significantly shorter than many NHS pathways. This rapid turnaround not only benefits patients but also positions the company favorably in contracts with NHS commissioners seeking to reduce elective surgery backlogs.

Financially, One Health’s focus on high-demand specialties like foot and ankle surgery offers a resilient revenue stream. The company treats approximately 17,000 new patients annually, with foot and ankle procedures representing a significant portion of this volume. The combination of specialized services, patient satisfaction, and efficient operations makes One Health an attractive proposition for investors interested in the healthcare sector.

One Health Group PLC (LON:OHGR) are a team of Consultant Surgeons and Healthcare managers working with the NHS to provide faster, local and expert care in Orthopaedics, Spinal, General Surgery and Gynaecology.

Share on:
Find more news, interviews, share price & company profile here for:

One Health Group FY25 revenue up 22%, record NHS demand

One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion.

One Health Group submits full planning application for first Surgical Hub

One Health Group plc has exchanged contracts to acquire land for its first Surgical Hub in Northern England, with planning approval anticipated soon.

One Health Group raises £7.8 million, Admission to AIM

One Health Group plc has officially joined AIM, raising £7.8 million for its first surgical hub, enhancing patient care and operational efficiency in NHS-funded procedures.

One Health Group plc raises £7.5m and plans AIM listing 

The Company confirms the anticipated admission of the Enlarged Issued Share Capital of the Company to trading on AIM on 20 March 2025.

One Health Group raised £0.2 million in Retail Offer

One Health Group plc (AQSE:OHGR) announces successful Retail and Placing Offer with a capital raise of £7.5M, boosting shareholder opportunities.

One Health Group to raise gross proceeds of £8.0 million, admission to AIM

One Health Group plc (AQSE:OHGR) announces a £8 million fundraising to support its first surgical hub, with offers for shareholders and retail investors.

Search

Search